The ebullient Kent, an Australian of Hungarian extraction, hopes to launch the print side of Aussie-quoted hard copy and internet publisher Aspermont, which he has built in five years into Australia’s leading publisher for resource businesses, making 25 per cent on expected annual revenues of £2 million.
He plans to grow Aspermont, which produces Australia’s Mining Monthly and operates several websites, by merger and acquisition into a £50 million-a-year concern and cast its net overseas. A potential UK market of one million readers is envisaged.
The versatile Kent is also contemplating a £6 million AIM float for US-based Primedical, distributor of a newly developed blood pressure monitor. This can be fitted to a user’s clothes, shoes or jewellery, adjusted for different time intervals and can also recommend appropriate drugs and be used at home.
Primedical distributes an equivalent electrocardiogram monitor and is talking to the National Health Service and US medical insurers. Kent, meanwhile, intends to float Magyar Mining, with potentially between 1.7 million and 20 million oz of gold in Hungary and backed by RAB Capital. He also hopes to bring Abra Resources, with a possible two million tonnes of lead in Western Australia, to AIM.
Kent felt unfairly treated by Stock Exchange apparatchiks over TC Coombs. If he can pull these floats off, he will hail a belated vindication.
